Respiratory Measurement Devices Market

Respiratory Measurement Devices Market Overview (2022 to 2032)

The global Respiratory Measurement Devices Market was valued at around USD 7.9 Billion at the end of 2021. The market is projected to register a 5.1% CAGR and top a valuation of USD 13.5 Billion by 2032.

Increase in prevalence of sleep apnea, rise in geriatric population and increase in demand for non-invasive painless tests is expected to uplift the respiratory measurement devices market growth.

Respiratory monitoring aids in the detection of sleep disorders associated with a diurnal movement disorder. To obtain information on respiratory and sleeping habits polysomnography (PSG) is used. Spirometers and smart pulse oximeters are types of respiratory monitoring devices that assist in monitoring patients' respiratory conditions.

The treatment of patients with respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory failure depends heavily on respiratory monitoring. Respiratory monitoring plays a crucial role in the management of these patients. It helps the medical professional to reach out concluding decision and choose the method of treatment for the patient.

Attributes	Details
Respiratory Measurement Devices Market Value in 2021	USD 7.9 Billion
Respiratory Measurement Devices Market Value in 2032	USD 13.5 Billion
Respiratory Measurement Devices Market CAGR (2022 to 2032)	5.1%

What Are The Major Drivers Boosting The Demand For Respiratory Measurement Devices Market?

An increase in the prevalence of sleep apnea and respiratory diseases boosted the demand for respiratory monitoring devices. Furthermore, the rising geriatric population propelling the demand of the market. In older populations age causes a person's immune system to deteriorate.

Therefore, the risk of developing diseases in this age group increases due to the surge in the geriatric population. The risk of developing and contracting respiratory diseases increases with the age.

The market for respiratory monitoring devices is constantly developing new products that will be rising monitoring accuracy and enhancing patient comfort. Research and Development on novel systems by key manufacturers have been seen as a lucrative growth opportunity in the forecasted period.

The demand for novel products such as wearables, cordless devices, smartphones, and integrated devices, caused by the rapid advancement of technology is being accepted more quickly, propelling the market's expansion.

Which Region Shows Strong Growth Potential In The Respiratory Measurement Devices Market?

In comparison to other regions, North America has the greatest market for respiratory measurement device sales and makes the most contribution. Due to the existence of well-established key players that provide respiratory measurement devices and approval from the Food and Drug Administration (FDA) for the products.

Due to the increased emphasis on respiratory care management in homecare settings, Europe is predicted to have the fastest-growing demand for respiratory measurement devices. Due to the region's increasingly aging population, rising consumer awareness, and growing medical tourism in developing nations like China, South Asia is forecasting strong development for the respiratory monitoring devices market.

Who Are The Key Players In The Respiratory Measurement Devices Market?

Medtronic, Philips Healthcare, Smiths Medical, Drgerwerk AG Co. KGaA, GE Healthcare, Welch Allyn, Inc., Masimo, MGC Diagnostics Corporation, Vyaire Medical, Inc., Nihon Kohden Corporation, Novelda AS, Welch Allyn, Inc., Masimo, Getinge Inc., Resmed, Siemens Healthcare.

Scope Of Report

Report Attributes	Details
Growth Rate	CAGR of 5.1% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segment Covered	Product, Indication, End User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East Africa (MEA)
Key Countries Profiled	The USA, Canada, Brazil, Mexico, Germany, The UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Players	Medtronic; Philips Healthcare; Smiths Medical; Drgerwerk AG Co. KGaA; GE Healthcare; Welch Allyn, Inc.; Masimo; MGC Diagnostics Corporation; Vyaire Medical, Inc.; Nihon Kohden Corporation; Novelda AS; Welch Allyn, Inc.; Masimo, Getinge Inc.; Resmed; Siemens Healthcare.
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Product
  • 6.2. Indication
  • 6.3. End User
• 7. Global Market Analysis and Forecast, By Product
  • 7.1. Pulse Oximeters
  • 7.2. Capnographs
  • 7.3. Spirometers
  • 7.4. Polysomnographs (PSG)
  • 7.5. Peak Flow Meters
  • 7.6. Gas Analyzers
  • 7.7. Others
• 8. Global Market Analysis and Forecast, By Indication
  • 8.1. Sleep Apnea
  • 8.2. COPD
  • 8.3. Asthma
  • 8.4. Infectious Disease
• 9. Global Market Analysis and Forecast, By End User
  • 9.1. Home Care
  • 9.2. Hospitals
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics
• 10. Global Market Analysis and Forecast, By Region
  • 10.1. North America
  • 10.2. Latin America
  • 10.3. Europe
  • 10.4. East Asia
  • 10.5. South Asia
  • 10.6. Oceania
  • 10.7. Middle East & Africa (MEA)
• 11. North America Sales Analysis and Forecast, by Key Segments and Countries
• 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 15. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 17. Middle East & Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 18. Sales Forecast by Product, Indication, and End User for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. Medtronic
  • 20.2. Philips Healthcare
  • 20.3. Smiths Medical
  • 20.4. Drägerwerk AG & Co. KGaA
  • 20.5. GE Healthcare
  • 20.6. Welch Allyn Inc.
  • 20.7. Masimo
  • 20.8. MGC Diagnostics Corporation
  • 20.9. Vyaire Medical Inc.
  • 20.10. Nihon Kohden Corporation
  • 20.11. Novelda AS
  • 20.12. Welch Allyn Inc.
  • 20.13. Masimo Getinge Inc.
  • 20.14. Resmed
  • 20.15. Siemens Healthcare